Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors
Leap Therapeutics, Inc.
Leap Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
The University of Texas Health Science Center at San Antonio
Blueprint Medicines Corporation
Ipsen
Atara Biotherapeutics
Jonsson Comprehensive Cancer Center
University of Colorado, Denver
Janssen Research & Development, LLC
Sarcoma Alliance for Research through Collaboration
Barbara Ann Karmanos Cancer Institute
CytRx
Bayer
University of Texas Southwestern Medical Center